Cargando…

Triterpenoid–PEG Ribbons Targeting Selectivity in Pharmacological Effects

(1) Background: To compare the effect of selected triterpenoids with their structurally resembling derivatives, designing of the molecular ribbons was targeted to develop compounds with selectivity in their pharmacological effects. (2) Methods: In the synthetic procedures, Huisgen 1,3-dipolar cycloa...

Descripción completa

Detalles Bibliográficos
Autores principales: Özdemir, Zulal, Bildziukevich, Uladzimir, Čapková, Martina, Lovecká, Petra, Rárová, Lucie, Šaman, David, Zgarbová, Michala, Lapuníková, Barbora, Weber, Jan, Kazakova, Oxana, Wimmer, Zdeněk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391127/
https://www.ncbi.nlm.nih.gov/pubmed/34440155
http://dx.doi.org/10.3390/biomedicines9080951
_version_ 1783743198084988928
author Özdemir, Zulal
Bildziukevich, Uladzimir
Čapková, Martina
Lovecká, Petra
Rárová, Lucie
Šaman, David
Zgarbová, Michala
Lapuníková, Barbora
Weber, Jan
Kazakova, Oxana
Wimmer, Zdeněk
author_facet Özdemir, Zulal
Bildziukevich, Uladzimir
Čapková, Martina
Lovecká, Petra
Rárová, Lucie
Šaman, David
Zgarbová, Michala
Lapuníková, Barbora
Weber, Jan
Kazakova, Oxana
Wimmer, Zdeněk
author_sort Özdemir, Zulal
collection PubMed
description (1) Background: To compare the effect of selected triterpenoids with their structurally resembling derivatives, designing of the molecular ribbons was targeted to develop compounds with selectivity in their pharmacological effects. (2) Methods: In the synthetic procedures, Huisgen 1,3-dipolar cycloaddition was applied as a key synthetic step for introducing a 1,2,3-triazole ring as a part of a junction unit in the molecular ribbons. (3) Results: The antimicrobial activity, antiviral activity, and cytotoxicity of the prepared compounds were studied. Most of the molecular ribbons showed antimicrobial activity, especially on Staphylococcus aureus, Pseudomonas aeruginosa, and Enterococcus faecalis, with a 50–90% inhibition effect (c = 25 µg·mL(−1)). No target compound was effective against HSV-1, but 8a displayed activity against HIV-1 (EC(50) = 50.6 ± 7.8 µM). Cytotoxicity was tested on several cancer cell lines, and 6d showed cytotoxicity in the malignant melanoma cancer cell line (G-361; IC(50) = 20.0 ± 0.6 µM). Physicochemical characteristics of the prepared compounds were investigated, namely a formation of supramolecular gels and a self-assembly potential in general, with positive results achieved with several target compounds. (4) Conclusions: Several compounds of a series of triterpenoid molecular ribbons showed better pharmacological profiles than the parent compounds and displayed certain selectivity in their effects.
format Online
Article
Text
id pubmed-8391127
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83911272021-08-28 Triterpenoid–PEG Ribbons Targeting Selectivity in Pharmacological Effects Özdemir, Zulal Bildziukevich, Uladzimir Čapková, Martina Lovecká, Petra Rárová, Lucie Šaman, David Zgarbová, Michala Lapuníková, Barbora Weber, Jan Kazakova, Oxana Wimmer, Zdeněk Biomedicines Article (1) Background: To compare the effect of selected triterpenoids with their structurally resembling derivatives, designing of the molecular ribbons was targeted to develop compounds with selectivity in their pharmacological effects. (2) Methods: In the synthetic procedures, Huisgen 1,3-dipolar cycloaddition was applied as a key synthetic step for introducing a 1,2,3-triazole ring as a part of a junction unit in the molecular ribbons. (3) Results: The antimicrobial activity, antiviral activity, and cytotoxicity of the prepared compounds were studied. Most of the molecular ribbons showed antimicrobial activity, especially on Staphylococcus aureus, Pseudomonas aeruginosa, and Enterococcus faecalis, with a 50–90% inhibition effect (c = 25 µg·mL(−1)). No target compound was effective against HSV-1, but 8a displayed activity against HIV-1 (EC(50) = 50.6 ± 7.8 µM). Cytotoxicity was tested on several cancer cell lines, and 6d showed cytotoxicity in the malignant melanoma cancer cell line (G-361; IC(50) = 20.0 ± 0.6 µM). Physicochemical characteristics of the prepared compounds were investigated, namely a formation of supramolecular gels and a self-assembly potential in general, with positive results achieved with several target compounds. (4) Conclusions: Several compounds of a series of triterpenoid molecular ribbons showed better pharmacological profiles than the parent compounds and displayed certain selectivity in their effects. MDPI 2021-08-03 /pmc/articles/PMC8391127/ /pubmed/34440155 http://dx.doi.org/10.3390/biomedicines9080951 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Özdemir, Zulal
Bildziukevich, Uladzimir
Čapková, Martina
Lovecká, Petra
Rárová, Lucie
Šaman, David
Zgarbová, Michala
Lapuníková, Barbora
Weber, Jan
Kazakova, Oxana
Wimmer, Zdeněk
Triterpenoid–PEG Ribbons Targeting Selectivity in Pharmacological Effects
title Triterpenoid–PEG Ribbons Targeting Selectivity in Pharmacological Effects
title_full Triterpenoid–PEG Ribbons Targeting Selectivity in Pharmacological Effects
title_fullStr Triterpenoid–PEG Ribbons Targeting Selectivity in Pharmacological Effects
title_full_unstemmed Triterpenoid–PEG Ribbons Targeting Selectivity in Pharmacological Effects
title_short Triterpenoid–PEG Ribbons Targeting Selectivity in Pharmacological Effects
title_sort triterpenoid–peg ribbons targeting selectivity in pharmacological effects
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391127/
https://www.ncbi.nlm.nih.gov/pubmed/34440155
http://dx.doi.org/10.3390/biomedicines9080951
work_keys_str_mv AT ozdemirzulal triterpenoidpegribbonstargetingselectivityinpharmacologicaleffects
AT bildziukevichuladzimir triterpenoidpegribbonstargetingselectivityinpharmacologicaleffects
AT capkovamartina triterpenoidpegribbonstargetingselectivityinpharmacologicaleffects
AT loveckapetra triterpenoidpegribbonstargetingselectivityinpharmacologicaleffects
AT rarovalucie triterpenoidpegribbonstargetingselectivityinpharmacologicaleffects
AT samandavid triterpenoidpegribbonstargetingselectivityinpharmacologicaleffects
AT zgarbovamichala triterpenoidpegribbonstargetingselectivityinpharmacologicaleffects
AT lapunikovabarbora triterpenoidpegribbonstargetingselectivityinpharmacologicaleffects
AT weberjan triterpenoidpegribbonstargetingselectivityinpharmacologicaleffects
AT kazakovaoxana triterpenoidpegribbonstargetingselectivityinpharmacologicaleffects
AT wimmerzdenek triterpenoidpegribbonstargetingselectivityinpharmacologicaleffects